Equity Overview
Price & Market Data
Price: $0.052
Daily Change: -$1.35 / 2,592%
Daily Range: $0 - $0
Market Cap: $28,246,985
Daily Volume: 0
Performance Metrics
1 Week: -96.29%
1 Month: -96.29%
3 Months: -96.29%
6 Months: -94.80%
1 Year: -94.80%
YTD: -96.29%
Details
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.